Combined intravitreal bevacizumab and photodynamic therapy with vertiporfin for management of choroidal neovascularization secondary to age-related macular degeneration

References

• AielloLPBruckerAJChangS2004Evolving guidelines for intra-vitreal injectionsRetina24S3S1915483476
   PubMed Web of Science ®Google Scholar
• AveryRLPieramiciDJRabenaMD2006Bevacizumab Intraviteal (Avastin) for neovascular age-related macular degenerationOphthalmology1133637216458968
   PubMed Web of Science ®Google Scholar
• BergersGSongSnMeyer-MorseE2003Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitorsJ Clin Invest11112879512727920
   PubMed Web of Science ®Google Scholar
• BrownDMKaiserPKMichelsM2006Ranibizumab versus verteporfin for neovascular age-related macular degenerationN Engl J Med35514324417021319
   PubMed Web of Science ®Google Scholar
• ChanWMLaiTYWongAL2006Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularization in age-related macular degeneration: a comparative studyBr J Ophthalmol903374116488958
   PubMed Web of Science ®Google Scholar
• CiullaTACriswellMHDanisRP2001Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat modelArch Ophthalmol11939940411231773
   PubMed Web of Science ®Google Scholar
• DanisRPBingamanDPYangY1996Inhibition of pre-retinal and optic nerve head neovascularization in pigs by itravitreal triamcinolone acetonideOphthalmology10320991049003344
   PubMed Web of Science ®Google Scholar
• DhallaMSGauravKShahMD2006Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degenerationRetina269889317151484
   PubMed Web of Science ®Google Scholar
• ErberRThurnherAKatsenAD2004Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediate endothelial cell survival mechanismsFASEB J183384014657001
   PubMed Web of Science ®Google Scholar
• FlowerRWvon KerczekCZhoL2001Theoretical investigation of the role of choriocapillaries blood flow in the treatment of subfoveal choroidal neovascularization associated with age-related macular degenerationAm J Ophthalmol132859311438059
   PubMed Web of Science ®Google Scholar
• GilliesMCSimpsonJMBillsonFA2004Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trialArch Ophthalmol1223364015006845
   PubMed Web of Science ®Google Scholar
• GragoudasESAdamisAPCunninghamET2004Pegaptanib for neovascular age-related macular degenerationN Engl J Med35128051615625332
   PubMed Web of Science ®Google Scholar
• GrunewaldMAvrahamIDorY2006VEGF-induced adult neovascularization: recrutement, retension, and role of accessory cellsCell1241758916413490
   PubMed Web of Science ®Google Scholar
• HeierJSAntoszykANPavanPR2006Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose studyOphthalmology1136334216483659
   PubMed Web of Science ®Google Scholar
• JonasJBKreissigIHuggerP2003Intravitreal triamcinilone acetonide for exudative age related macular degenerationBr J Ophthalmol87462812642311
   PubMed Web of Science ®Google Scholar
• LazicRGabricN2007Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degenerationOphthalmology11411798517544776
   PubMed Web of Science ®Google Scholar
• MillerJW2005Randomized, controlled phase III of ranibizumab (Lucentis) for minimally classic or occult neovascular age-related macular degenerationPresented at American Society of Retina Specialists Annual MeetingJuly 2005Montreal, Quebec, Canada
   Google Scholar
• MoshfeghiDMKaiserPKGrossniklausHE2003Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with vertiporfin ocular photodynamic therapyAm J Ophthalmol1353435012614752
   PubMed Web of Science ®Google Scholar
• RechtmanEDanisRPPrattLM2004Intravitreal Triamcinolone with photodynamic therapy for subfoveal choroidal neovascularization in age related macular degenerationBr J Ophthalmol88344714977766
   PubMed Web of Science ®Google Scholar
• RogersAHMartidisAGreenbergBP2002Optical coherence tomography findings following photodynamic therapy of choroidal neovascularizationAm J Ophthalmol1345666712383814
   PubMed Web of Science ®Google Scholar
• RosenfeldPJBrownDMHeierJS2006Ranibizumab for neovascular age-related macular degenerationN Engl J Med35514193117021318
   PubMed Web of Science ®Google Scholar
• RosenfeldPJ2006Intravitreal Avastin: the low cost alternative to Lucentis?Am J Ophthalmol142141316815262
   PubMed Web of Science ®Google Scholar
• RosenfieldPJMoshfeghiAAPuliqfitoCA2005Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degenerationOphthalmic Surg Lasers Imaging36331516156152
   PubMedGoogle Scholar
• Schmidt-ErfurthUSchlutzer-SchrehardUCursiefenC2003Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium driven factorInvest Opthtalmol Vis Sci44447380
   PubMed Web of Science ®Google Scholar
• SpaideRFSorensonJMarananLCombined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularizationOphthalmology11015172512917166
   PubMed Web of Science ®Google Scholar
• SpaideRFSorensonJMarananL2005Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularizationOphthalmology112301415691567
   PubMed Web of Science ®Google Scholar
• SpaideRF2006Rationale for combination therapies for choroidal neovascularizationAm J Ophthalmol1411495616386991
   PubMed Web of Science ®Google Scholar
• [TAP] Treatment of Age-Related Macular Degeneration With Photodynamic Therapy study group1999Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials – TAP reportArch Ophthalmol11713294510532441
   PubMedGoogle Scholar
• [VIP] Verteporfin in Photodynamic Therapy Report 22001Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of randomized clinical trial inkling lesions with occult and no classic choroidal neovascularizationAm J Ophthalmol1315416011336929
   PubMed Web of Science ®Google Scholar
• WachtlinJBehmiTHeinmannH2003Concentric retinal pigment epithelium atrophy after single photodynamic therapyGraefes Arch Clin Exp Opthtalmol24151821
   PubMed Web of Science ®Google Scholar